One of the mechanisms to restrain AML is the inhibition of a key protein nuclear factor κB (NF-κB) with the involvement of the JAK/STAT signaling pathway, which transcriptionally regulates stress-response genes. The gene discussed is NFKB1; the disease is acute myeloid leukemia.